Trials / Unknown
UnknownNCT04548414
Homocysteine in Patients With Sepsis
The Effect of Homocysteine on the Prognosis of Patients With sepsis-an Observational Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Nanjing University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
After stimulation by lipopolysaccharide (LPS), the one-carbon metabolism of macrophages was significantly up-regulated, the expression of key enzyme 5,10-methylenetetrahydrofolate reductase increased. In vitro experiments we found that LPS stimulation can increase the expression of MTHFR mRNA and protein in macrophages, suggesting that aerobic glycolysis may trigger cytokine storm through one-carbon metabolism. Homocysteine (homocysteine, Hcy) is an important intermediate product of one-carbon metabolism. A number of studies have shown that Hcy is positively correlated with the level of pro-inflammatory factors, significantly enhancing cytokine storm. However, the relationship between Hcy and serum pro-inflammatory factors in patients with sepsis and the effect of Hcy on the prognosis of patients with sepsis are still unclear. Based on the previous work, our research group intends to carry out single-center, prospective, observational clinical research to observe the relationship between homocysteine and the mortality of patients with sepsis, and to provide new indicators for accurately judging the prognosis of sepsis , To provide new targets for clinical development of drugs for the treatment of sepsis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No. | This is an observational study with no intervention. |
Timeline
- Start date
- 2020-09-20
- Primary completion
- 2022-05-19
- Completion
- 2022-09-19
- First posted
- 2020-09-14
- Last updated
- 2020-09-14
Source: ClinicalTrials.gov record NCT04548414. Inclusion in this directory is not an endorsement.